Viral particles support prophylactic vaccination against breast cancer
Artificial structures of tumour antigens, so-called mimotopes, applied in vaccinations of cancer patients can trigger a long-term immune response. For the vaccine, however, a carrier is required that triggers an immune response ...
Oct 11, 2016
0
1